Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,102 | 2,835 | 6,951 | 4,407 | 4,849 |
| Marketable Securities | 11,088 | 13,051 | 11,790 | 9,793 | 6,523 |
| Receivables | 1,655 | 1,717 | 486 | 777 | 608 |
| Inventories | 2,042 | 3,712 | 1,575 | 1,068 | 812 |
| Other current assets | 298 | 413 | 639 | 526 | 219 |
| TOTAL | $17,185 | $21,728 | $21,441 | $16,571 | $13,010 |
| Non-Current Assets | |||||
| PPE Net | N/A | 10,235 | N/A | N/A | N/A |
| Investments And Advances | 1,592 | 1,558 | 1,525 | 1,493 | 1,462 |
| Other Non-Current Assets | 2,511 | 2,753 | 1,532 | 1,623 | 1,752 |
| TOTAL | $4,103 | $14,546 | $3,057 | $3,116 | $3,214 |
| Total Assets | $26,444 | $31,115 | $29,900 | $24,454 | $20,488 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 280 | 280 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 551 | 590 | 294 | 725 | 320 |
| Accrued Expenses | 1,097 | 532 | 0 | 0 | 0 |
| Other current liabilities | 2,400 | 3,000 | 3,946 | 1,359 | 846 |
| TOTAL | $4,329 | $7,300 | $4,241 | $2,084 | $1,169 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,631 | 3,672 | 4,000 | 4,000 | 3,995 |
| TOTAL | $3,631 | $3,672 | $4,000 | $4,000 | $3,995 |
| Total Liabilities | $7,959 | $10,971 | $8,241 | $6,084 | $5,164 |
| Shareholders' Equity | |||||
| Common Shares | 53,248 | 130 | 52,852 | 48,648 | 44,643 |
| Retained earnings | -34,763 | -33,082 | -31,193 | -30,278 | -29,320 |
| Other shareholders' equity | 0 | 2,301 | 0 | -1 | 1 |
| TOTAL | $18,485 | $20,143 | $21,659 | $18,369 | $15,324 |
| Total Liabilities And Equity | $26,444 | $31,114 | $29,900 | $24,453 | $20,488 |